150 related articles for article (PubMed ID: 3801500)
1. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.
Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Kruizinga W
Biochim Biophys Acta; 1987 Feb; 917(2):238-46. PubMed ID: 3801500
[TBL] [Abstract][Full Text] [Related]
2. Increased (23R)-hydroxylase activity in patients suffering from cerebrotendinous xanthomatosis, resulting in (23R)-hydroxylation of bile acids.
Koopman BJ; Wolthers BG; Van der Molen JC; Nagel GT; Rutgers H; Strijtveen B; Kaptein B
Biochim Biophys Acta; 1986 Oct; 883(3):585-92. PubMed ID: 3756224
[TBL] [Abstract][Full Text] [Related]
3. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Waterreus RJ; Oosterhuis HJ
Clin Chim Acta; 1984 Sep; 142(1):103-11. PubMed ID: 6478619
[TBL] [Abstract][Full Text] [Related]
4. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.
Batta AK; Arora R; Salen G; Tint GS; Eskreis D; Katz S
J Lipid Res; 1989 Dec; 30(12):1953-62. PubMed ID: 2621422
[TBL] [Abstract][Full Text] [Related]
5. A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.
Kimura S; Beppu T; Kugai N; Koide Y; Fujita T; Iida K; Yamashita N; Yamashita K; Seyama Y
Jpn J Med; 1982 Jul; 21(3):210-5. PubMed ID: 7143816
[TBL] [Abstract][Full Text] [Related]
6. Identification of short side chain bile acids in urine of patients with cerebrotendinous xanthomatosis.
Kuramoto T; Furukawa Y; Nishina T; Sugimoto T; Mahara R; Tohma M; Kihira K; Hoshita T
J Lipid Res; 1990 Oct; 31(10):1895-902. PubMed ID: 2079611
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
Wolthers BG; Volmer M; van der Molen J; Koopman BJ; de Jager AE; Waterreus RJ
Clin Chim Acta; 1983 Jun; 131(1-2):53-65. PubMed ID: 6883710
[TBL] [Abstract][Full Text] [Related]
8. Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.
Koopman BJ; Wolthers BG; van der Molen JC; Waterreus RJ
Clin Chim Acta; 1985 Oct; 152(1-2):115-22. PubMed ID: 4053393
[TBL] [Abstract][Full Text] [Related]
9. Bile acid profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Kihira K; Shimazu K; Kuwabara M; Yoshii M; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
Steroids; 1986; 48(1-2):109-19. PubMed ID: 3660436
[TBL] [Abstract][Full Text] [Related]
10. Capillary gas chromatography of urine samples in diagnosing cerebrotendinous xanthomatosis.
Bouwes Bavinck JN; Vermeer BJ; Gevers Leuven JA; Koopman BJ; Wolthers BG
Arch Dermatol; 1986 Nov; 122(11):1269-72. PubMed ID: 3777973
[TBL] [Abstract][Full Text] [Related]
11. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
Berginer VM; Salen G; Shefer S
N Engl J Med; 1984 Dec; 311(26):1649-52. PubMed ID: 6504105
[TBL] [Abstract][Full Text] [Related]
13. Serum bile acid profiles in cerebrotendinous xanthomatosis.
Beppu T; Seyama Y; Kasama T; Serizawa S; Yamakawa T
Clin Chim Acta; 1982 Feb; 118(2-3):167-75. PubMed ID: 7055978
[TBL] [Abstract][Full Text] [Related]
14. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
Salen G; Tint GS; Eliav B; Deering N; Mosbach EH
J Clin Invest; 1974 Feb; 53(2):612-21. PubMed ID: 11344576
[TBL] [Abstract][Full Text] [Related]
15. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
Batta AK; Shefer S; Batta M; Salen G
J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647
[TBL] [Abstract][Full Text] [Related]
16. Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of deoxycholic acid.
Wolthers BG; van der Molen JC; Walrecht H; Hesselmans LF
Clin Chim Acta; 1990 Dec; 193(3):113-8. PubMed ID: 2282689
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
Nakagawa M; Colombo C; Setchell KD
Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
Stiehl A; Rudolph G; Raedsch R; Möller B; Hopf U; Lotterer E; Bircher J; Fölsch U; Klaus J; Endele R
Hepatology; 1990 Sep; 12(3 Pt 1):492-7. PubMed ID: 2401455
[TBL] [Abstract][Full Text] [Related]
19. Case of cerebrotendinous xanthomatosis. I: Unusual ophthalmic features.
Morgan SJ; McKenna P; Bosanquet RC
Br J Ophthalmol; 1989 Dec; 73(12):1011-4. PubMed ID: 2611184
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
Batta AK; Salen G; Tint GS
Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
